Archangels
investing in innovation
?>


lab901

Lab 901 was sold to Agilent Technologies, a US listed company, in 2011. The original investment by Archangels was made in 2002.

Lab901’s revolutionary ScreenTape product automates a traditional bio-analysis process used by thousands of scientists and clinicians around the world. ScreenTape enables diagnostic and life science research labs to achieve rapid and accurate results effortlessly and is now sold across 5 continents.

Related Works.

Loading

Vitrology

Vitrology

Stem Cell Sciences

Stem Cell Sciences

Optos

Optos

Mpathy Medical

Mpathy Medical

Flexitricity

Flexitricity

Data Discoveries

Data Discoveries

Crombie Anderson

Crombie Anderson

Website user management

Website user management

Bespoke high value investigative toxicology studies

Bespoke high value investigative toxicology studies

Next generation middle ear implants

Next generation middle ear implants

World-leading prosthetic technologies

World-leading prosthetic technologies